Merck KGaA: confident for growth in 2019
(CercleFinance.com) - The Merck KGaA stock is up 1% in Frankfurt today, while the German pharmaceutical, chemical and life sciences company says that it expects to "return with a profitable growth" with regard to its key figures from 2019, at its investor day.
In particular, the group says that it aims for its life sciences activities to continue to target profitable growth which outperforms the market and that its performance materials business is adapting its research and development.
Merck also confirms its targets for 2018, as presented at its interim publication, which, on an organic basis, include adjusted EBITDA that is down 1% to 3%, revenue growth of 3% to 5% and adjusted EPS of between 5 euros and 5.40 euros.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
In particular, the group says that it aims for its life sciences activities to continue to target profitable growth which outperforms the market and that its performance materials business is adapting its research and development.
Merck also confirms its targets for 2018, as presented at its interim publication, which, on an organic basis, include adjusted EBITDA that is down 1% to 3%, revenue growth of 3% to 5% and adjusted EPS of between 5 euros and 5.40 euros.
Copyright (c) 2018 CercleFinance.com. All rights reserved.